Publication:
Cost-effective use of prereferral treatment for severe malaria

Simple item page
dc.contributor.authorYoel Lubellen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.date.accessioned2018-09-24T09:13:30Z
dc.date.available2018-09-24T09:13:30Z
dc.date.issued2010-12-04en_US
dc.identifier.citationThe Lancet. Vol.376, No.9756 (2010), 1880-1881en_US
dc.identifier.doi10.1016/S0140-6736(10)61969-1en_US
dc.identifier.issn01406736en_US
dc.identifier.other2-s2.0-78649833293en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/29346
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=78649833293&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleCost-effective use of prereferral treatment for severe malariaen_US
dc.typeNoteen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=78649833293&origin=inwarden_US

Files

Collections

Scopus 2006-2010